Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity

Peter Teismann, Kinnari Sathe, Angelika Bierhaus, Lin Leng, Heather L Martin, Richard Bucala, Bernd Weigle, Peter P. Nawroth, Jörg B. Schulz

Research output: Contribution to journalArticle

34 Citations (Scopus)
15 Downloads (Pure)

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder of unknown pathogenesis characterized by the loss of nigrostriatal dopaminergic neurons. Oxidative stress, microglial activation and inflammatory responses seem to contribute to the pathogenesis. The receptor for advanced glycation endproducts (RAGE) is a multiligand receptor of the immunoglobulin superfamily of cell surface molecules. The formation of advanced glycation end products (AGEs), the first ligand of RAGE identified, requires a complex series of reactions including nonenzymatic glycation and free radical reactions involving superoxide-radicals and hydrogen peroxide. Binding of RAGE ligands results in activation of nuclear factor-kappaB (NF-¿B). We show that RAGE ablation protected nigral dopaminergic neurons against cell death induced by the neurotoxin MPTP that mimics most features of PD. In RAGE-deficient mice the translocation of the NF-¿B subunit p65 to the nucleus, in dopaminergic neurons and glial cells was inhibited suggesting that RAGE involves the activation of NF-¿B. The mRNA level of S100, one of the ligands of RAGE, was increased after MPTP treatment. The dopaminergic neurons treated with MPP+ and S100 protein showed increased levels of apoptotic cell death, which was attenuated in RAGE-deficient mice. Our results suggest that activation of RAGE contributes to MPTP/MPP+-induced death of dopaminergic neurons that may be mediated by NF-¿B activation.
Original languageEnglish
Pages (from-to)2478-2490
Number of pages13
JournalNeurobiology of Aging
Volume33
Issue number10
Early online date9 Jan 2012
DOIs
Publication statusPublished - Oct 2012

Fingerprint

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Dopaminergic Neurons
Ligands
Parkinson Disease
Cell Death
Advanced Glycosylation End Product-Specific Receptor
Advanced Glycosylation End Products
S100 Proteins
Neurotoxins
Substantia Nigra
Neuroglia
Superoxides
Neurodegenerative Diseases
Hydrogen Peroxide
Free Radicals
Immunoglobulins
Oxidative Stress
Messenger RNA

Keywords

  • MPTP
  • NF-¿B
  • Parkinson's disease
  • RAGE
  • neuroprotection
  • microglia
  • astrocytes

Cite this

Teismann, P., Sathe, K., Bierhaus, A., Leng, L., Martin, H. L., Bucala, R., ... Schulz, J. B. (2012). Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. Neurobiology of Aging, 33(10), 2478-2490. https://doi.org/10.1016/j.neurobiolaging.2011.12.006

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. / Teismann, Peter; Sathe, Kinnari; Bierhaus, Angelika; Leng, Lin; Martin, Heather L; Bucala, Richard; Weigle, Bernd; Nawroth, Peter P.; Schulz, Jörg B.

In: Neurobiology of Aging, Vol. 33, No. 10, 10.2012, p. 2478-2490.

Research output: Contribution to journalArticle

Teismann, P, Sathe, K, Bierhaus, A, Leng, L, Martin, HL, Bucala, R, Weigle, B, Nawroth, PP & Schulz, JB 2012, 'Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity', Neurobiology of Aging, vol. 33, no. 10, pp. 2478-2490. https://doi.org/10.1016/j.neurobiolaging.2011.12.006
Teismann, Peter ; Sathe, Kinnari ; Bierhaus, Angelika ; Leng, Lin ; Martin, Heather L ; Bucala, Richard ; Weigle, Bernd ; Nawroth, Peter P. ; Schulz, Jörg B. / Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. In: Neurobiology of Aging. 2012 ; Vol. 33, No. 10. pp. 2478-2490.
@article{88f54acbd3e841f9b8da01e6261becec,
title = "Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity",
abstract = "Parkinson's disease (PD) is a common neurodegenerative disorder of unknown pathogenesis characterized by the loss of nigrostriatal dopaminergic neurons. Oxidative stress, microglial activation and inflammatory responses seem to contribute to the pathogenesis. The receptor for advanced glycation endproducts (RAGE) is a multiligand receptor of the immunoglobulin superfamily of cell surface molecules. The formation of advanced glycation end products (AGEs), the first ligand of RAGE identified, requires a complex series of reactions including nonenzymatic glycation and free radical reactions involving superoxide-radicals and hydrogen peroxide. Binding of RAGE ligands results in activation of nuclear factor-kappaB (NF-¿B). We show that RAGE ablation protected nigral dopaminergic neurons against cell death induced by the neurotoxin MPTP that mimics most features of PD. In RAGE-deficient mice the translocation of the NF-¿B subunit p65 to the nucleus, in dopaminergic neurons and glial cells was inhibited suggesting that RAGE involves the activation of NF-¿B. The mRNA level of S100, one of the ligands of RAGE, was increased after MPTP treatment. The dopaminergic neurons treated with MPP+ and S100 protein showed increased levels of apoptotic cell death, which was attenuated in RAGE-deficient mice. Our results suggest that activation of RAGE contributes to MPTP/MPP+-induced death of dopaminergic neurons that may be mediated by NF-¿B activation.",
keywords = "MPTP, NF-¿B, Parkinson's disease, RAGE, neuroprotection, microglia, astrocytes",
author = "Peter Teismann and Kinnari Sathe and Angelika Bierhaus and Lin Leng and Martin, {Heather L} and Richard Bucala and Bernd Weigle and Nawroth, {Peter P.} and Schulz, {J{\"o}rg B.}",
note = "Copyright {\circledC} 2011 Elsevier Inc. All rights reserved.",
year = "2012",
month = "10",
doi = "10.1016/j.neurobiolaging.2011.12.006",
language = "English",
volume = "33",
pages = "2478--2490",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "10",

}

TY - JOUR

T1 - Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity

AU - Teismann, Peter

AU - Sathe, Kinnari

AU - Bierhaus, Angelika

AU - Leng, Lin

AU - Martin, Heather L

AU - Bucala, Richard

AU - Weigle, Bernd

AU - Nawroth, Peter P.

AU - Schulz, Jörg B.

N1 - Copyright © 2011 Elsevier Inc. All rights reserved.

PY - 2012/10

Y1 - 2012/10

N2 - Parkinson's disease (PD) is a common neurodegenerative disorder of unknown pathogenesis characterized by the loss of nigrostriatal dopaminergic neurons. Oxidative stress, microglial activation and inflammatory responses seem to contribute to the pathogenesis. The receptor for advanced glycation endproducts (RAGE) is a multiligand receptor of the immunoglobulin superfamily of cell surface molecules. The formation of advanced glycation end products (AGEs), the first ligand of RAGE identified, requires a complex series of reactions including nonenzymatic glycation and free radical reactions involving superoxide-radicals and hydrogen peroxide. Binding of RAGE ligands results in activation of nuclear factor-kappaB (NF-¿B). We show that RAGE ablation protected nigral dopaminergic neurons against cell death induced by the neurotoxin MPTP that mimics most features of PD. In RAGE-deficient mice the translocation of the NF-¿B subunit p65 to the nucleus, in dopaminergic neurons and glial cells was inhibited suggesting that RAGE involves the activation of NF-¿B. The mRNA level of S100, one of the ligands of RAGE, was increased after MPTP treatment. The dopaminergic neurons treated with MPP+ and S100 protein showed increased levels of apoptotic cell death, which was attenuated in RAGE-deficient mice. Our results suggest that activation of RAGE contributes to MPTP/MPP+-induced death of dopaminergic neurons that may be mediated by NF-¿B activation.

AB - Parkinson's disease (PD) is a common neurodegenerative disorder of unknown pathogenesis characterized by the loss of nigrostriatal dopaminergic neurons. Oxidative stress, microglial activation and inflammatory responses seem to contribute to the pathogenesis. The receptor for advanced glycation endproducts (RAGE) is a multiligand receptor of the immunoglobulin superfamily of cell surface molecules. The formation of advanced glycation end products (AGEs), the first ligand of RAGE identified, requires a complex series of reactions including nonenzymatic glycation and free radical reactions involving superoxide-radicals and hydrogen peroxide. Binding of RAGE ligands results in activation of nuclear factor-kappaB (NF-¿B). We show that RAGE ablation protected nigral dopaminergic neurons against cell death induced by the neurotoxin MPTP that mimics most features of PD. In RAGE-deficient mice the translocation of the NF-¿B subunit p65 to the nucleus, in dopaminergic neurons and glial cells was inhibited suggesting that RAGE involves the activation of NF-¿B. The mRNA level of S100, one of the ligands of RAGE, was increased after MPTP treatment. The dopaminergic neurons treated with MPP+ and S100 protein showed increased levels of apoptotic cell death, which was attenuated in RAGE-deficient mice. Our results suggest that activation of RAGE contributes to MPTP/MPP+-induced death of dopaminergic neurons that may be mediated by NF-¿B activation.

KW - MPTP

KW - NF-¿B

KW - Parkinson's disease

KW - RAGE

KW - neuroprotection

KW - microglia

KW - astrocytes

U2 - 10.1016/j.neurobiolaging.2011.12.006

DO - 10.1016/j.neurobiolaging.2011.12.006

M3 - Article

C2 - 22227007

VL - 33

SP - 2478

EP - 2490

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 10

ER -